Previous Issue - Issue 53

ahhm-current-issue

Issue 53 | 2023

  • Foreword
  • Research & Development
  • Clinical Trials
  • Manufacturing
  • Expert Corner
  • Advertorials
  • Go to Digital Magazine

Issue 53

PREVIOUS ISSUE

Research & Development

FROM DISCOVERY TO DELIVERY

Neuronal exosomes and the evolution of neurodegenerative disease treatment

The rising challenge of Neurodegenerative diseases NDDs including Alzheimers Parkinsons Huntingtons disease

Recent Advances in Small-molecule Broad-spectrum Inhibitors of Bacterial Metallo-β-lactamases

Incessant resistance of pathogenic bacteria to almost all forms of antibiotics continues to pose a major threat to human wellbeing worldwide

Powering Decentralised Drug Development

Enabling downstream disruptive technologies to generate high fidelity output

The Decentralised Drug Development DDD process involves coordinating various vendors and pulling together contract research organisations

Deuterated Drugs In The Covid-19 Pandemic

Since the recent approval by the FDA to commercialise and administer deutetrabenazine

ANTS: NON-INVASIVE TECHNIQUE FOR EARLY DETECTION OF CANCER

Early detection of cancer is critical for successful treatment and improved patient outcomes

Enabling the delivery of the poorly soluble and unstable drugs to the site of action

The drug discovery pipeline is composed of around per cent molecules with low solubility

Clinical Trials

Revolutionising Clinical Trials with Real-time Data

Clinical trials have long been the cornerstone of medical progress providing the practical base upon which new treatments

Getting The Most Out of Your Clinical Trial

Collecting human factors data to improve commercial device design

Human factors engineering HFE is crucial in developing an effective device and is critical to meeting global regulatory expectations

REVOLUTIONISING CLINICAL TRIALS

Harnessing data and real-time action for better healthcare

The past five years have seen the AsiaPacific APAC region emerge as a global hub for clinical trials attracting pharmaceutical companies

Manufacturing

How to Overcome The Hurdle of Immunotherapy

For most people only vaccines come to mind when they think of immunotherapy